Marzetti’s (MZTI) Record Streak Hits a Wall With Outbreak and Guidance Cut

Marzetti Company (MZTI) reached a record streak in fiscal year 2026 with record net sales, gross profit and operating income. However, an outbreak of Cyclospora has hit a wall in the company's growth, with first-quarter net sales expected to decline by 250 basis points. The company is guiding to a 15% decline in first-quarter operating income due to the outbreak, long-term debt from the acquisition of Bachan's, and higher commodity inflation.

Despite the challenges, Marzetti still has record cash flow, a fast-growing Bachan's platform, and twelve straight quarters of margin gains. The risks ahead include the outbreak, added debt, and a higher tax rate, but the company's management believes in its long-term potential.